Research Hub

Neutral summaries of peer-reviewed studies with links to the full papers.

BMAC for Grade 3–4 Knee Osteoarthritis (Heliyon, 2018)

Retrospective cohort (n=233) reporting improvements in pain and function after a single intra-articular BMAC injection.

Bone Marrow Concentrate for Hip OA (Registry Results)

Prospective registry describing pain and Oxford Hip Score changes and reported safety after BMC for hip osteoarthritis.

HA-BMAC vs Microfracture (5-Year Cartilage Repair)

Comparative cohort showing durability of function scores with HA scaffold + BMAC versus microfracture for knee cartilage lesions.

Allogeneic BM-MSC for Knee OA (Randomized Trial)

RCT comparing allogeneic BM-MSC to hyaluronic acid with clinical and MRI T2-mapping outcomes at 12 months.

Orthopedic Applications of Stem Cell Therapy — Policy

BCBS policy overview and FDA HCT/P considerations (21 CFR 1271) related to orthobiologics in orthopedic care.